News
Hosted on MSN11mon
Merck nears $1.3 bln takeover of Eyebiotech- WSJInvesting.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech ... is expected to pay $1.3 billion in cash for the ophthalmology firm, and could pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results